Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: Jack Hartmann who wrote (51659)	12/27/1999 10:59:00 PM
From: EtTuBrute	Respond to of 108040

TGAL: Here is the excerpt from Thom Calandra re: TGAL: One private California investor has two companies lined up. Glenn Cutler tells me Tegal Corp. (TGAL: news, msgs) has, quote, unquote, "explosive upside potential." Cutler has had a hot hand this year. Tegal is a semiconductor equipment maker. It uses plasma etch systems. Some big computer chip makers are evaluating Tegal's patented system, Cutler says. Tegal's $3.50 stock could hit 20 next year, he says. Here is more extensive comments on TGAL: Former fund manager Glenn Cutler tells me Tegal Corp. (TGAL: news, msgs) has "explosive upside potential." Cutler has had a hot hand this year. (See previous column.) Tegal is a California semiconductor equipment maker that uses plasma-etch systems. Some big computer chip makers are evaluating Tegal's patented system, Cutler says. Tegal's $3.50 stock could hit 20 next year, he says. (Note: Tegal's market capitalization on Nasdaq was $36 million as of Monday morning. A "CBS MarketWatch Weekend" television graphic stated an incorrect market cap for the company.) "This may be the only legitimate semiconductor equipment manufacturer that hasn't gotten a good play in this market," says Cutler, a onetime analyst and newsletter writer whose work I have followed since 1986. "They have a leading-edge technology in plasma-etch systems. They recently got an order for a system from RF Micro Devices . . . and many leading semiconductor companies are evaluating this system now." Cutler acknowledges the company is tiny. "But those are the kinds of companies you look at for a January effect -- small, unloved," he says. Tegal stock, he says, "has the potential for the $15 to $20 range, especially if the order flow on the high-end equipment keeps picking up," he says. Tegal shares Monday rose 2 15/32 to 5 13/16 as 18.3 million shares changed hands. The stock was Nasdaq's second-most active issue Monday.

To: Jack Hartmann who wrote (51659)	12/27/1999 11:10:00 PM
From: EtTuBrute	Respond to of 108040

BIME: Looks like an earnings play. Looks like the company is going to record a good profit, not bad for a $1 biotech NASDAQ company with only 2 million shares out. Already have through 3 quarters .15/sh profit: LOS ANGELES (CBS.MW) -- Biomune Systems soared 61 percent Monday ahead of the company's fourth-quarter earnings report. Today on CBS MarketWatch Nasdaq ekes out record gain Investors roil Amazon.com shares Upgrade lifts Knight/Trimark shares CDNow hits 3 mln holiday customers StockWatch: An eye on the January effect, Part I More top stories... CBS MarketWatch Columns Updated: 12/27/99 5:22:50 PM ET Could it be the fundamentals and earnings? According to Market Guide, the company (BIME: news, msgs) recorded a loss of $34.49 a share for 1996, a loss of $52.34 a share in 1997 and a loss of $6.88 a share in 1998. However, the biopharmaceutical products company is on its way to reporting a positive number for 1999. The company posted a first-quarter profit of 5 cents, a second-quarter profit of 6 cents a share and a third-quarter profit of 4 cents a share. The company is slated to report fourth-quarter earnings Dec. 29 Shares were last trading up 17/32 to close at 1 13/32.